The Deal Register
Database › Equity financing › Devonian Health Group Announces Proposed Listing on the NYSE American…

Equity financing

Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public…

Lane
Equity financing
Announced
27 Jul 2026
Province
Quebec
Industry
Healthcare & life sciences
Status
Announced
What the filing says
Devonian Health Group Inc. (" Devonian " or the " Company ") (TSXV: GSD ) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering").
Source

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe